Despite steady revenue decline, investors are questionably m...
Despite steady revenue decline, investors are questionably maintaining the P/S ratio, a seemingly unsustainable move that may negatively impact share price. The overvalued P/S ratio indicates a premium payment for the stock amidst a bleak revenue foresight.
Lushang Freda Pharmaceutical Co.,Ltd.'s (SHSE:600223) Shares May Have Run Too Fast Too Soon
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment